Your browser doesn't support javascript.
loading
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.
Chan, Stephen L; Cheng, Paul N M; Liu, Angela M; Chan, Landon L; Li, Leung; Chu, Cheuk M; Chong, Charing C N; Lau, Yat M; Yeo, Winnie; Ng, Kelvin K C; Yu, Simon C H; Mok, Tony S K; Chan, Anthony W H.
Afiliación
  • Chan SL; State Key Laboratory of Translational Oncology, Hong Kong, China. chanlam_stephen@cuhk.edu.hk.
  • Cheng PNM; Department of Clinical Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong, China. chanlam_stephen@cuhk.edu.hk.
  • Liu AM; Bio-Cancer Treatment International Ltd., Hong Kong, China.
  • Chan LL; Bio-Cancer Treatment International Ltd., Hong Kong, China.
  • Li L; Department of Oncology, Princess Margaret Hospital, Hong Kong, China.
  • Chu CM; Department of Clinical Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong, China.
  • Chong CCN; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China.
  • Lau YM; Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
  • Yeo W; Department of Clinical Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong, China.
  • Ng KKC; Department of Clinical Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong, China.
  • Yu SCH; Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
  • Mok TSK; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China.
  • Chan AWH; State Key Laboratory of Translational Oncology, Hong Kong, China.
Invest New Drugs ; 39(5): 1375-1382, 2021 10.
Article en En | MEDLINE | ID: mdl-33856599
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ornitina Carbamoiltransferasa / Arginasa / Argininosuccinato Sintasa / Proteínas Recombinantes / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ornitina Carbamoiltransferasa / Arginasa / Argininosuccinato Sintasa / Proteínas Recombinantes / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos